Physician Assistant · Marysville, MI
NPI
1831166768
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3350 Gratiot Blvd
Marysville, MI, 48040
Phone (810) 364-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
919 services
Medicare patients, 2024
221
Average age 73
Drug cost, 2024
$613K
6,401 prescriptions
Company payments, 2025
$2,918
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Todd P Stachowiak was code 99213 (office e&m - established), 219 times for 144 patients. In total Todd P Stachowiak billed 919 services in 56 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 219 | 144 | $45.84 | $10K |
| 99214 Office E&M - Established | Office | 213 | 112 | $63.73 | $14K |
| 83036 Blood Count | Office | 90 | 46 | $8.89 | $800 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 81 | 81 | $104.22 | $8,442 |
| 81003 Clinical Chemistry | Office | 47 | 31 | $2.20 | $103 |
| 71046 X-ray - Chest | Office | 19 | 17 | $19.74 | $375 |
| 93000 Electrocardiogram | Office | 18 | 17 | $7.61 | $137 |
| 96372 Injection Administration | Office | 14 | 11 | $7.76 | $109 |
By year: 2022 $40K for 923 services; 2023 $44K for 926 services; 2024 $40K for 919 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 90 | 46 | $8.89 | $800 |
| 81003 Clinical Chemistry | 47 | 31 | $2.20 | $103 |
Medicare prescription drug claims, 2024
In 2024, the drug Todd P Stachowiak prescribed most often to Medicare patients was Atorvastatin Calcium, with 339 prescriptions and refills. In total Todd P Stachowiak wrote 6,401 Medicare prescriptions that cost $613K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 339 | 882 | 97 | $4,479 |
| Levothyroxine Sodium Generic | 277 | 673 | 61 | $3,217 |
| Amlodipine Besylate Generic | 252 | 620 | 62 | $1,355 |
| Omeprazole Generic | 213 | 495 | 59 | $2,409 |
| Lisinopril Generic | 179 | 483 | 51 | $1,416 |
| Losartan Potassium Generic | 172 | 433 | 45 | $2,207 |
| Hydrochlorothiazide Generic | 137 | 340 | 34 | $653 |
| Metoprolol Succinate Generic | 133 | 337 | 34 | $2,249 |
| Famotidine Generic | 114 | 256 | 27 | $1,761 |
| Metformin Hcl Er Metformin Hcl | 104 | 259 | 32 | $1,150 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 102 | 102 | 11 | $1,320 |
| Trazodone Hcl Generic | 101 | 163 | 19 | $823 |
| Simvastatin Generic | 101 | 286 | 27 | $910 |
| Metformin Hcl Generic | 90 | 240 | 25 | $1,116 |
| Metoprolol Tartrate Generic | 90 | 227 | 28 | $565 |
Brand drugs: 747 claims; generic drugs: 5,611 claims; opioid claims: 194.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Todd P Stachowiak $2,918 ($2,918 in general payments such as food, travel and fees) from 26 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $558.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 22 | $558 |
| Abbvie Inc. ABBV | 22 | $403 |
| Vanda Pharmaceuticals Inc. VNDA | 13 | $338 |
| Novo Nordisk Inc NVO | 22 | $306 |
| Lilly USA, LLC LLY | 11 | $148 |
| Amgen Inc. AMGN | 13 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $118 |
| Axsome Therapeutics, Inc. AXSM | 4 | $84.26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $81.97 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $68.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.